Blackwell Burke P.A. Again Named to the BTI Client Service A-Team List for 2018
This is significant, because the annual BTI Client Service A-Team ranking is limited solely to law firms considered by clients to deliver the absolute best levels of client service. It is the only law firm ranking based solely on objective feedback from corporate counsel. In addition to being previously recognized on the BTI Client Service […]
Blackwell Burke P.A. Sponsors Minnesota Hispanic Bar Association Gala
Blackwell Burke P.A. was proud to be a platinum sponsor of the 13th annual Minnesota Hispanic Bar Association (MHBA) gala, which was held on March 2, 2018, in Minneapolis. The event honored Tamara Caban-Ramirez and Senator Melisa Lopez Franzen, recipients of the 2018 Manuel Guerrero Courage in Leadership Award. Named for one of the founders […]
Two New Attorneys Join Blackwell Burke P.A.
Two new litigators, Ted Hartman and Patrick Hauswald, recently joined Blackwell Burke P.A., deepening the already-diverse skill set at the boutique law firm. About Ted Hartman Ted Hartman brings litigation experience in products liability, premises liability, commercial litigation, real estate law, and contract disputes. Before joining Blackwell Burke P.A., Hartman spent two years in private […]
Jerry Blackwell on Selection Committee Appointing First Hmong Judge in Minnesota
Continuing his commitment to diversity in the courtroom, Blackwell Burke founder Jerry Blackwell was part of Governor Mark Dayton’s Judicial Selection Commission that recommended the appointment of Minnesota’s first Hmong judge, Sophia Vuelo. “It’s important in a system of justice that the judges that get appointed reflect the ethnic, cultural, and gender diversity of our […]
Jerry W. Blackwell Wins Minnesota Diversity & Inclusion Award
The first annual Minnesota Lawyer-Diversity & Inclusion Awards honor those who have contributed to the advancement of diversity and inclusion in the practice of law, going above and beyond in creating a more diverse and inclusive community. When Jerry Blackwell founded Blackwell Burke P.A., he wove excellence and diversity into the firm’s DNA based on […]
Three Blackwell Burke P.A. Attorneys Listed on the Benchmark Litigation 2017 “Under 40 Hotlist”
The Benchmark Litigation “2017 40 under 40 List” honors the achievements of the nation’s most accomplished legal partners of the age of forty or younger. Blackwell Burke P.A. is proud of its three attorneys receiving this recognition. Gerardo “Jerry” Alcazar’s practice includes products liability, commercial litigation, and other complex matters often involving high stakes litigation. […]
Blackwell Burke P.A. Secures Dismissal of Putative, National Window Class Action
Blackwell Burke P.A. recently secured a complete defense victory on behalf of a national window manufacturer. Plaintiffs alleged negligent product design and manufacture, breach of express and implied warranties, and fraud, on behalf of a putative, national consumer class in a Minnesota federal district court. The lawsuit arose from plaintiffs’ contention that the insulated glass […]
Benchmark Litigation Presents Blackwell Burke P.A. with Minnesota Firm of the Year Award
On February 16, 2017, Blackwell Burke was honored as the “Minnesota Firm of the Year” at the Benchmark Litigation 2017 US awards. The event, held at the Essex House Hotel in New York City, recognized the top litigation firms in all 50 states. Partner Peter Goss attended the Benchmark Litigation 2017 US Awards ceremony and […]
Peter Goss Analyzes New Jersey Summary Judgment Order in Talc Suits against Johnson & Johnson
Peter Goss was quoted in Law360’s analysis of a recent New Jersey trial court ruling in the Johnson & Johnson talc litigation. The order excluded the plaintiffs’ experts’ testimony and dismissed the claims of two women who alleged that exposure to bath talc caused their ovarian cancer. (“J&J Talc Suits Show Evidence Standards Vary Among […]
Peter Goss Comments on Emerging Appellate Split on Generic Drug Preemption
Peter Goss commented for Law360 on a recent ruling by the New Jersey Supreme Court finding no federal preemption where the generic drug manufacturer’s label for metoclopramide (Reglan) did not match that of the brand. (“NJ Reglan Ruling Widens Generic Label Preemption Split,” available with subscription here.) Goss noted that the decision conflicted with Fifth and Sixth […]